Autoimmune hepatitis: What must be said

Experimental and Molecular Pathology

Volumn 93, Issue 3, 2012, Pages 350-353

  Mackay, Ian R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Autoimmunity; Chronic hepatitis; Drugs as autoimmune instigators; Genetics of autoimmune hepatitis; History of autoimmune hepatitis; Liver autoantigens

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CORTICOSTEROID; CYTOCHROME P450 2D6; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CHRONIC ACTIVE HEPATITIS; DISEASE CLASSIFICATION; GENETIC PREDISPOSITION; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LIVER CELL; LIVER CIRRHOSIS; PLASMACYTOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SEROLOGY; T LYMPHOCYTE;

AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS;

EID: 84870657360     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.11.001     Document Type: Article

References (29)

1. Bharadwaj M., Illing P., Theodossis A., Purcell A.W., Rossjohn J., McCluskey J. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annual Review of Pharmacology and Toxicology 2012, 52:401-431.
2. Bogdanos D.P., Invernizzi P., Mackay I.R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World Journal of Gastroenterology 2008, 14:3374-3387.
3. Burnet F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. The Australian Journal of Science 1957, 20:67-69.
4. Burnet F.M. The Clonal Selection Theory of Acquired Immunity 1959, Cambridge University Press, London.
5. H17 T cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007, 110:3804-3813.
6. Cruse J.M., Lewis R.E. David W. Talmage and the advent of the cell selection theory of antibody synthesis. Journal of Immunology 1994, 153:919-929.
7. Fairfax K., Mackay I.R., Mackay F. BAFF/BLyS inhibitors: a new prospect for treatment of systemic lupus erythematosus. IUBMB Life 2012, 64:595-602.
8. Grabar P. Hypothesis. Autoantibodies and immunological theories: an analytic review. Clinical Immunology and Immunopathology 1975, 4:453-466.
9. Johnson P.J., McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
10. Lleo A., Selmi S., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apoptosis and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
11. + regulatory T cells in health and autoimmune hepatitis. Journal of Immunology 2006, 176:4484-4491.
12. Mackay I.R. The etiopathogenesis of autoimmunity. Seminars in Liver Disease 2005, 25:239-250.
13. Mackay I.R. Historical reflections on autoimmune hepatitis. World Journal of Gastroenterology 2008, 14:3292-3300.
14. Mackay I.R. Travels and travails of autoimmunity: an historical journey from discovery to rediscovery. Autoimmunity Reviews 2010, 9:A251-A258.
15. Mackay I.R. Autoimmune hepatitis: from the clinic to the diagnostics laboratory. Laboratory Medicine 2011, 42:224-233.
16. Mackay I.R. A 50-year experience with autoimmune hepatitis: and where are we now. Journal of Gastroenterology 2011, 46(Supplement 1):17-28.
17. Mackay I.R., Burnet F.M. Autoimmune Disease: Pathogenesis, Chemistry and Therapy 1963, Charles C Thomas, Springfield IL.
18. Mackay I.R., Weiden S., Hasker J. Autoimmune hepatitis. Annals of the New York Academy of Sciences 1965, 124:767-780.
19. Mackay I.R., Martinez-Neira R., Whittingham S. Autoantigenicity of actin. Actin, Actin-binding Proteins and Disease 2008, 50-64. Springer, New York, USA, (Chapter 4). C. dos Remedios, D. Chhabra (Eds.).
20. Oo Y.H., Adams D.H. Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?. Journal of Hepatology 2012, 57:6-8.
21. Page A.R., Good R.A. Plasma cell hepatitis with special attention to steroid therapy. Journal of Diseases of Children 1960, 99:288-314.
22. Roberts-Thomson P.J., Jackson M.W., Gordon T.P. A seminal monograph: Mackay and Burnet's Autoimmune Diseases. The Medical Journal of Australia 2012, 196:74-76.
23. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004, 22:531-562.
24. Searle J., Harmon B.V., Bishop C.J., Kerr J.F.R. The significance of cell death by apoptosis in hepatobiliary disease. Journal of Gastroenterology and Hepatology 1987, 2:77-96.
25. Silverstein A.M. Autoimmunity: a history of the early struggle for recognition. The Autoimmune Diseases 2006, 3-9. Academic Press. 4th edition. N.R. Rose (Ed.).
26. Tahiri F., Le Naour F., Huguet S., Lai-Kuen R., Samuel D., Johanet C., et al. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology 2008, 47:937-948.
27. Vergani D., Mielo-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World Journal of Gastroenterology 2008, 14:3306-3312.
28. Yadav M., Louvet C., Davini D., Gardner J.M., Martinez-Llordella M., Bailey-Bucktrout S., et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. The Journal of Experimental Medicine 2012, 209:1713-1722.
29. Zhang J.G., Czabotar P.E., Policheni A.N., Caminschi I., Wan S.S., Kitsoulis S., et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012, 36:646-657.